HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoying Zhou Selected Research

Histamine Agents

9/2022Anti-histamine effects of dipotassium glycyrrhizinate on lung fibroblasts, implicating its therapeutic mechanism for pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoying Zhou Research Topics

Disease

42Neoplasms (Cancer)
12/2022 - 11/2010
22Nasopharyngeal Carcinoma
01/2021 - 11/2010
15Infections
01/2020 - 02/2010
14Neoplasm Metastasis (Metastasis)
04/2021 - 11/2010
11Stomach Neoplasms (Stomach Cancer)
03/2020 - 06/2014
10Liver Cirrhosis (Hepatic Cirrhosis)
08/2009 - 03/2002
7Asthma (Bronchial Asthma)
01/2021 - 02/2015
6Inflammation (Inflammations)
01/2022 - 06/2019
6Fibrosis (Cirrhosis)
01/2017 - 03/2002
5Renal Cell Carcinoma (Grawitz Tumor)
11/2021 - 01/2019
5Carcinogenesis
11/2021 - 11/2010
4Experimental Arthritis
12/2021 - 01/2017
4Carcinoma (Carcinomatosis)
06/2020 - 07/2011
3Prostatic Neoplasms (Prostate Cancer)
12/2022 - 01/2021
3Necrotizing Enterocolitis
07/2021 - 11/2020
3Food Hypersensitivity (Food Allergy)
01/2021 - 01/2018
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 12/2016
2Atopic Dermatitis (Atopic Eczema)
01/2022 - 01/2021
2Rheumatoid Arthritis
12/2021 - 10/2017
2Pathologic Constriction (Stenosis)
01/2021 - 09/2013
2Esophageal Stenosis (Esophageal Stricture)
01/2021 - 09/2013
2Breast Neoplasms (Breast Cancer)
12/2020 - 09/2020
2Body Weight (Weight, Body)
01/2019 - 01/2016
2Adenocarcinoma of Lung
01/2016 - 11/2014
1Pulmonary Fibrosis (Fibrosing Alveolitis)
09/2022
1Prediabetic State (Prediabetes)
06/2022
1COVID-19
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Critical Illness (Critically Ill)
01/2022
1Pleural Effusion (Pleural Effusions)
01/2022
1Periodontitis
12/2021

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
06/2020 - 06/2004
10Biomarkers (Surrogate Marker)IBA
04/2021 - 06/2014
7Matrix Metalloproteinases (MMPs)IBA
12/2021 - 03/2002
7Messenger RNA (mRNA)IBA
03/2020 - 03/2002
7Long Noncoding RNAIBA
01/2020 - 01/2015
7MicroRNAs (MicroRNA)IBA
09/2019 - 06/2014
6EnzymesIBA
01/2021 - 04/2014
6CollagenIBA
03/2020 - 03/2002
5CytokinesIBA
01/2022 - 08/2015
5Chymases (Chymase)IBA
12/2021 - 02/2015
4Biological ProductsIBA
06/2020 - 01/2015
4Prostaglandins DIBA
11/2016 - 11/2015
3Pharmaceutical PreparationsIBA
12/2022 - 01/2017
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2022 - 10/2019
3diazonaphthalenedisulfonic acid (NDS)IBA
12/2022 - 10/2019
3Interleukin-10 (Interleukin 10)IBA
01/2022 - 01/2018
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2015
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
12/2021 - 10/2004
3LipidsIBA
01/2021 - 05/2020
3Cadherins (E-Cadherin)IBA
06/2020 - 10/2011
3Tryptases (Tryptase)IBA
01/2019 - 03/2002
3Cathepsin CIBA
12/2018 - 01/2017
3Cisplatin (Platino)FDA LinkGeneric
08/2017 - 06/2014
3Phosphotransferases (Kinase)IBA
12/2014 - 01/2005
3Tissue Inhibitor of Metalloproteinase-1IBA
08/2009 - 03/2002
2Peptides (Polypeptides)IBA
12/2022 - 06/2014
2SaltsIBA
09/2022 - 01/2016
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2019
2AllergensIBA
01/2022 - 01/2021
2InflammasomesIBA
01/2021 - 01/2021
2OligosaccharidesIBA
01/2021 - 11/2020
2Immunoglobulin E (IgE)IBA
01/2021 - 01/2021
2hydrogen sulfite (bisulfite)IBA
01/2021 - 08/2011
2Ketone BodiesIBA
01/2021 - 01/2017
2RNA (Ribonucleic Acid)IBA
01/2021 - 06/2019
2InterleukinsIBA
01/2021 - 03/2016
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 08/2015
2MineralsIBA
05/2020 - 01/2016
2IronIBA
05/2020 - 01/2020
2Competitive Endogenous RNAIBA
01/2020 - 09/2019
2GelatinasesIBA
01/2019 - 12/2018
2AntibodiesIBA
11/2018 - 01/2015
2AntigensIBA
11/2018 - 10/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 08/2015
2Membrane Proteins (Integral Membrane Proteins)IBA
06/2017 - 01/2017
2Diphosphonates (Bisphosphonates)IBA
01/2017 - 11/2014
2Transcription Factors (Transcription Factor)IBA
10/2015 - 01/2011
2Cytochromes b5 (Cytochrome b5)IBA
08/2015 - 04/2014
2Oxidoreductases (Dehydrogenase)IBA
08/2015 - 04/2014
2Monomeric GTP-Binding ProteinsIBA
11/2014 - 10/2012
2Collagenases (Collagenase)FDA Link
01/2003 - 03/2002
1Small Interfering RNA (siRNA)IBA
12/2022
1antineoplaston A10 (A 10)IBA
12/2022
1Glycyrrhizic Acid (Glycyrrhizin)IBA
09/2022
1Histamine AgentsIBA
09/2022
1Histamine (Histamine Dihydrochloride)FDA Link
09/2022
1ElectrolytesIBA
06/2022
1PotassiumIBA
06/2022
1SodiumIBA
06/2022
1CreatinineIBA
01/2022
1Serum AlbuminIBA
01/2022
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2022
1BradykininIBA
12/2021
1Peptide Hydrolases (Proteases)FDA Link
12/2021
1Hyaluronic Acid (Hyaluronan)IBA
12/2021

Therapy/Procedure

12Therapeutics
11/2021 - 09/2013
2Precision Medicine
12/2022 - 11/2019
2Drug Therapy (Chemotherapy)
03/2015 - 06/2014
1Castration
12/2022